Results: The serum C (250.9*38.5 vs.1137.0~24.5mgldl
While reports suggest that the prevalence of cardiovascular risk factors (CV RF) in acute myocardial infarction (Ml) may be low. there is a paucity of data on the prevalence of modifiable CV RF among patients with Ml in a geographically defined populatton, and it is not known whether the prevalence is changing over time.
OBJECTIVES:
To determine the overall prevalence of CV RF among patients with Ml in the population and their change over time DESIGN: Population-based MI incidence cohort.
METHODS:
We analyzed the prevalence of major modlflabk CV RF including over- In the Coronary Drug Project (CDP), niacin decreased recurrent nonfatal myocardial Infarction (NFMI) by 28% at 6 years (study end) and total mortality by 11% at 15 years (9 years post-trial). Since niacin may affect insulin sensitivity, and new national guidelines emphasize the importance of metabolic syndrome (MS), ws evaluated whether n&n's effects on clinical outcomes were similar in patients with and without MS. We therefore analyzed results in that subgroup from CDP using National Cholesterol Education Program Adult Treatment Panel Ill criteria.
Methods:
We defined MS as at least 3 of: triglycerides $50 mgldL; blood pressure ~130/>85 mmHg; fasting glucose 2110 but cl26 mg/dL; or body mass index >28 (as a substitute for waist circumference).
High - 
Conclusions:
We conclude that in the CDP, niacin reduced NFMI and mortality in patients both with and without MS. 
